• Je něco špatně v tomto záznamu ?

Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease

P. Wohlfahrt, S. Rokosny, V. Melenovsky, BA. Borlaug, V. Pecenkova, P. Balaz,

. 2016 ; 39 (9) : 654-9. [pub] 20160526

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031705
E-zdroje Online Plný text

NLK ProQuest Central od 2015-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2015-01-01 do Před 1 rokem

Odkazy

PubMed 27225601
DOI 10.1038/hr.2016.50
Knihovny.cz E-zdroje

In patients with end-stage renal disease, excessive blood flow through an arteriovenous fistula (AVF) may lead to volume overload-induced cardiac remodeling and heart failure. It is unclear which patients with hyperfunctional AVF may benefit from AVF reduction or ligation. The indication for the procedure is often based on AVF flow. Because cardiac remodeling is driven by increased venous return, which is equivalent to cardiac output, we hypothesized that an elevated cardiac index (CI) might better identify subjects with reverse remodeling after AVF reduction. Thirty patients (age 52±12 years, 73% male) with AVF flow ⩾1.5 l min(-1) underwent comprehensive echocardiographic evaluations before and after AVF reduction. At baseline, 16 patients had a normal CI (2.5-3.8 l min(-1) m(-2)) and 14 had a high CI (4.0-6.0 l min(-1) m(-2)). A left ventricular end-diastolic diameter decrease after operation was predicted by elevated baseline CI (P<0.01), but not elevated AVF flow (P=0.07). There was a significant decrease in CI, left ventricular mass, left atrial and right ventricular diameter and pulmonary systolic pressure in the high CI group but not in the normal CI group. After AVF reduction, systemic vascular resistance decreased in the normal CI group, whereas it did not change in the high CI group. In conclusion, reduction of high-flow AVF leads to reverse cardiac remodeling but only in patients with elevated CI. The variability of the response of systemic vascular resistance to AVF flow may explain this observation. Increased CI but not increased AVF flow may better determine candidates for AVF reduction.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031705
003      
CZ-PrNML
005      
20171102102953.0
007      
ta
008      
171025s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/hr.2016.50 $2 doi
035    __
$a (PubMed)27225601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Wohlfahrt, Peter $u Center for Cardiovascular Prevention of the First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic. Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic. International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
245    10
$a Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease / $c P. Wohlfahrt, S. Rokosny, V. Melenovsky, BA. Borlaug, V. Pecenkova, P. Balaz,
520    9_
$a In patients with end-stage renal disease, excessive blood flow through an arteriovenous fistula (AVF) may lead to volume overload-induced cardiac remodeling and heart failure. It is unclear which patients with hyperfunctional AVF may benefit from AVF reduction or ligation. The indication for the procedure is often based on AVF flow. Because cardiac remodeling is driven by increased venous return, which is equivalent to cardiac output, we hypothesized that an elevated cardiac index (CI) might better identify subjects with reverse remodeling after AVF reduction. Thirty patients (age 52±12 years, 73% male) with AVF flow ⩾1.5 l min(-1) underwent comprehensive echocardiographic evaluations before and after AVF reduction. At baseline, 16 patients had a normal CI (2.5-3.8 l min(-1) m(-2)) and 14 had a high CI (4.0-6.0 l min(-1) m(-2)). A left ventricular end-diastolic diameter decrease after operation was predicted by elevated baseline CI (P<0.01), but not elevated AVF flow (P=0.07). There was a significant decrease in CI, left ventricular mass, left atrial and right ventricular diameter and pulmonary systolic pressure in the high CI group but not in the normal CI group. After AVF reduction, systemic vascular resistance decreased in the normal CI group, whereas it did not change in the high CI group. In conclusion, reduction of high-flow AVF leads to reverse cardiac remodeling but only in patients with elevated CI. The variability of the response of systemic vascular resistance to AVF flow may explain this observation. Increased CI but not increased AVF flow may better determine candidates for AVF reduction.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a arteriovenózní píštěl $x diagnostické zobrazování $x patofyziologie $7 D001164
650    _2
$a echokardiografie $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdce $x diagnostické zobrazování $x patofyziologie $7 D006321
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x diagnostické zobrazování $x patofyziologie $x terapie $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dialýza ledvin $7 D006435
650    _2
$a remodelace komor $x fyziologie $7 D020257
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rokosny, Slavomir $u Vascular and Transplant Surgery Department, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
700    1_
$a Melenovsky, Vojtech $u Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
700    1_
$a Borlaug, Barry A $u Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
700    1_
$a Pecenkova, Vera $u Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
700    1_
$a Balaz, Peter $u Department of Surgery, Faculty Hospital Kralovske Vinohrady, 3rd Medical Faculty, Charles University, Prague, Czech Republic.
773    0_
$w MED00006041 $t Hypertension research official journal of the Japanese Society of Hypertension $x 1348-4214 $g Roč. 39, č. 9 (2016), s. 654-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27225601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171102103046 $b ABA008
999    __
$a ok $b bmc $g 1255298 $s 992732
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 39 $c 9 $d 654-9 $e 20160526 $i 1348-4214 $m Hypertension research $n Hypertens Res $x MED00006041
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace